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Abstract 
Heat shock proteins (HSP) are highly conserved across eukaryotic and prokaryotic species. 
These proteins play a role in response to cellular stressors, protecting cells from damage and 
facilitating recovery. In tumor cells, HSPs can have cytoprotective effects and interfere with 
apoptotic cascades. This study was performed to assess the prognostic and predictive values 
of the gene expression of HSP family members in canine osteosarcoma (OS) and their 
potential for targeted therapy. Gene expressions for HSP were assessed using quantitative 
PCR (qPCR) on 58 snap-frozen primary canine OS tumors and related to clinic-pathological 
parameters. A significant increased expression of HSP60 was found in relation to shorter 
overall survival and an osteoblastic phenotype. Therefore, the function of HSP60 was 
investigated in more detail. Immunohistochemical analysis revealed heterogeneous staining 
for HSP60 in tumors. The highest immunoreactivity was found in tumors of short surviving 
dogs. Next HSP expression was shown in a variety of canine and human OS cell lines by 
qPCR and Western blot. In two highly metastatic cell lines HSP60 expression was silenced 
using siRNA resulting in decreased cell proliferation and induction of apoptosis in both cell 
lines. It is concluded that overexpression of HSP60 is associated with a poor prognosis of OS 
and should be evaluated as a new target for therapy. 
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